Medical Cannabis for Anxiety in the UK

Anxiety disorders are among the most common mental health conditions in the UK. For patients who have not responded to first-line therapies, some specialist clinicians may consider cannabis-based medicines as part of a broader treatment strategy.

What is an Anxiety Disorder?

Anxiety is a normal human response to threat, but when it becomes persistent, excessive, and disproportionate to actual circumstances, it can develop into a clinical anxiety disorder. The category encompasses generalised anxiety disorder (GAD), social anxiety disorder, panic disorder, health anxiety, and specific phobias, among others. Anxiety frequently co-occurs with depression, PTSD, and other mental health conditions.

In the UK, anxiety disorders affect a significant proportion of the population at any given time, and they are a leading cause of reduced productivity, poor quality of life, and mental health-related healthcare use. Symptoms range from persistent worry and fear to physical manifestations including palpitations, shortness of breath, chest tightness, sleep disruption, and gastrointestinal disturbance.

First-line treatments recommended by NICE include cognitive behavioural therapy (CBT), SSRIs, SNRIs, and in some cases benzodiazepines for short-term relief. Despite these options, a proportion of patients experience treatment-resistant anxiety that significantly impairs their functioning.

Medical Cannabis and Anxiety — What Does the Evidence Say?

The relationship between cannabis and anxiety is complex and requires careful clinical consideration. At low doses, CBD in particular has demonstrated anxiolytic properties in clinical literature and preclinical research. CBD interacts with serotonin receptors (5-HT1A) and may modulate the fear response in a manner relevant to several anxiety conditions. At higher doses of THC, however, cannabis can paradoxically worsen anxiety, induce paranoia, or trigger panic — which is why product selection and dosing precision are especially important in this population.

Observational studies from jurisdictions with established medical cannabis programmes suggest that many anxiety patients report subjective improvements following treatment with cannabis-based medicines, particularly CBD-dominant products. NICE guidance does not currently recommend cannabis-based medicines as a first or second-line treatment for anxiety disorders. However, individual specialists may consider prescribing on a case-by-case basis for patients who have exhausted recommended options.

Who Qualifies for a Medical Cannabis Prescription for Anxiety?

• Formal diagnosis: A documented clinical diagnosis of an anxiety disorder (GAD, social anxiety, panic disorder, etc.).
• Failed conventional treatments: At least two recommended therapies tried — typically a combination of NICE-recommended psychological therapy and pharmacotherapy — without adequate and sustained benefit.
• Persistent and significant impairment: Ongoing anxiety symptoms that substantially impair daily functioning despite treatment.
• Careful suitability assessment: The prescribing specialist will assess your suitability carefully, often starting with CBD-dominant products given the risk that THC may worsen anxiety in susceptible individuals.
• No contraindications: A history of psychosis or significant substance misuse may preclude cannabis prescribing for anxiety.

Can You Get Medical Cannabis for Anxiety in the UK?

Yes — anxiety disorders are a recognised prescribing indication at most UK cannabis clinics, but with more conditions attached than for physical pain conditions. The key requirements are:

• A formal anxiety diagnosis (GAD, social anxiety disorder, panic disorder, or similar)
• Evidence that at least two conventional treatments have been tried without adequate relief
• Ongoing significant impairment to daily life despite current management
• No significant contraindications (severe psychosis history, active substance misuse)

If you have anxiety and have only tried one medication, or have not tried CBT, most clinics will recommend completing those pathways first. If you have tried multiple treatments without adequate benefit, you are likely to be assessed as eligible.

Medical Cannabis for Anxiety UK — Which Clinics Prescribe?

Most major UK cannabis clinics cover anxiety disorders. The key is choosing a clinic comfortable with mental health presentations and able to offer psychiatry-informed assessment:

• Releaf — anxiety and PTSD are among their most treated indications. App-based model. From £79.
• Zerenia Clinic — psychiatry-led ethos; well suited to anxiety, PTSD, and complex mental health presentations. From £99.
• Lyphe Clinic — broad coverage including GAD and social anxiety. Specialist access. From £99.
• Mamedica — anxiety alongside pain presentations. From £95.
• Sapphire Medical Clinics — comprehensive psychiatric assessment. From £150.

See our dedicated medical cannabis for anxiety guide for a detailed comparison of clinic suitability for anxiety presentations.

What Products Are Prescribed for Anxiety?

Product selection for anxiety is more conservative than for most conditions because THC can worsen anxiety at higher doses. The typical starting approach:

• CBD-dominant oils: The first-line product for most anxiety patients. CBD has anxiolytic evidence (5-HT1A receptor activity) without the risk of THC-induced anxiety worsening.
• Balanced CBD:THC oils (low THC): Used once CBD alone proves insufficient — introduced very cautiously with slow titration.
• High-THC products: Generally avoided for primary anxiety presentations. Used only in specific circumstances with very careful dose management.

What to Expect from a Medical Cannabis Consultation for Anxiety

A consultation for anxiety will be thorough. The specialist will take a detailed mental health history, covering the nature and duration of your anxiety, its impact on your life, all treatments tried, and any comorbid conditions such as depression or PTSD.

If the specialist considers a cannabis-based medicine appropriate, they are likely to recommend starting with a CBD-dominant or balanced CBD:THC product at a low dose, titrating cautiously upward under monitoring.

How Much Does Medical Cannabis Cost for Anxiety in the UK?

• Initial consultation: £79 to £200.
• Monthly medication: £100 to £350 per month depending on product type and dose.
• Follow-up appointments: £50 to £100 per session, typically monthly for the first few months.

Frequently Asked Questions — Medical Cannabis for Anxiety UK

Can cannabis make anxiety worse?

Yes, THC-containing products can worsen anxiety in some individuals, particularly at higher doses. This is why CBD-dominant products and careful dose titration are essential for anxiety patients.

Is CBD the same as medical cannabis for anxiety?

Over-the-counter CBD is widely available but subject to less stringent quality standards than medical-grade cannabis-based medicines prescribed by a specialist. Your specialist will determine which product is most appropriate.

Will I need to stop my current anxiety medication?

Not necessarily. Your specialist will review current medications and assess interactions. Never alter your medication without medical guidance.

Can I get a cannabis prescription for anxiety on the NHS?

NHS prescribing for anxiety disorders is not currently a standard pathway. Private specialist clinics represent the primary route for most UK patients.

What is the difference between anxiety and PTSD in terms of cannabis prescribing?

PTSD has a somewhat more established evidence base for cannabis-based medicines than generalised anxiety. If your anxiety is primarily trauma-related, your specialist may consider a PTSD-focused prescribing approach.